Clinical Schizophrenia and Related Psychoses
Clinical Schizophrenia and Related Psychoses is a journal indexed in SJR in Medicine (miscellaneous) and Psychiatry and Mental Health with an H index of 27. It has an SJR impact factor of 0,114 and it has a best quartile of Q4. It has an SJR impact factor of 0,114.
Metrics
Scimago and CountryOfPapers database fields
SJR Impact
0,114
H-index
27
Docs (year)
21
Docs 3y
115
Total refs
510
Cites 3y
57
Citable 3y
107
Cites/Doc 2y
0.44
Ref/Doc
24.29
Immediate OA
—
Embargoed OA
NPD
Non OA / Submission
—
Name good journals. Call out predatory ones.
Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.
Researcher reviews
Best articles by citations
Antipsychotics for patients with Wolff-Parkinson-White Syndrome
View moreWhy Not Clozapine?
View moreClinical News
View moreClinical News
View moreClinical News
View moreClinical News
View moreClinical Correlates of Initial Treatment Disengagement in First-Episode Psychosis
View moreClients' Perceptions of Effective Supports in Vocational Rehabilitation
View moreChildhood Stressors and Symptoms of Schizophrenia
View moreCan Transcranial Direct Current Stimulation Improve Cognitive Functioning in Adults with Schizophrenia?
View moreBlood Draw Barriers for Treatment with Clozapine and Development of a Point-of-Care Monitoring Device
View moreAttitudes Toward Medications and the Relationship to Outcomes in Patients with Schizophrenia
View moreAssessing Intimidation Using a Brief Intrusiveness Measure
View moreA Brief Review of a Brain Model for Schizophrenia and Other Psychotic Disorders Which Might Suggest Novel Treatment Modalities
View moreAntipsychotic Combination with Psychosocial Intervention on Outcome of Schizophrenia (ACPIOS): Rationale and Design of the Clinical Trial
View moreAnhedonia of Patients with Schizophrenia and Schizoaffective Disorder is Attributed to Personality-Related Factors Rather than to State-Dependent Clinical Symptoms
View moreAn Exploratory, Open-Label, Randomized Trial Comparing Risperidone Long-Acting Injectable with Oral Antipsychotic Medication in the Treatment of Early Psychosis
View moreAmelioration of Negative Symptoms in Schizophrenia by Escitalopram: A Double-Blind, Placebo-Controlled Clinical Trial
View moreAll Psychosis is Not Schizophrenia, Especially Not in Women
View moreAdvantages and Limitations of Newer Antipsychotics
View moreAdd-On Pregnenolone with L-Theanine to Antipsychotic Therapy Relieves Negative and Anxiety Symptoms of Schizophrenia: An 8-Week, Randomized, Double-Blind, Placebo-Controlled Trial
View moreA Review of Diffusion Tensor Imaging in Schizophrenia
View moreA Pilot Study to Determine a Prolactin Threshold that Identifies Improved Sexual Functioning when Switching from a Prolactin-Elevating to a Prolactin-Neutral Antipsychotic
View moreA Pilot Study of Cultural/Racial Differences in Patient Perspectives on Long-Acting Injectable Antipsychotics for the Treatment of Schizophrenia
View more